Social Media Monitoring Report on Yescarta, a drug by Gilead Sciences, Inc. for relapsed or ref..
Ex Tax: $3,999.00
This is a social media monitoring report on US FDA approval of Kisqali (ribociclib) a drug of Novart..
Ex Tax: $4,999.00
Social media listening study covering Sanofi & Regeneron’s, Kevzara (Sarilumab) drug which is re..
Ex Tax: $0.00
RA social media research report has been conducted based on online conversation of various stakehold..
Ex Tax: $5,999.00